Tungsten Advisors is an investment banking firm focused on strategic advisory and corporate finance for healthcare companies. Tungsten provides transactional services including financings (PPs/PIPEs/RDs), corporate licensing and mergers and acquisitions. Tungsten also focuses on company incubation and makes direct investments alongside the creation of new companies in healthcare.
Securities offered through Finalis Securities LLC Member FINRA/SIPC. Tungsten Partners LLC d/b/a Tungsten Advisors and Finalis Securities LLC are separate, unaffiliated entities.
Company Details
- Employees
- 3
- Founded
- 2019
- Address
- 767 3rd Ave, New York,new York 10017,united States
- Industry
- Investment Banking
- NAICS
-
Investment Banking and Securities Dealing
- Website
- http://www.tungstenadv.com
- HQ
- New York, New York
Tungsten Advisors Questions
Tungsten Advisors's website is http://www.tungstenadv.com
Tungsten Advisors's LinkedIn profile is https://www.linkedin.com/company/tungstenadv
Tungsten Advisors has
3 employees.
View email and phone details for 3
employees at Tungsten Advisors.
Tungsten Advisors's industry is
Investment Banking
Tungsten Advisors's top competitors are
Ferghana Partners,
Metis Pharmaceuticals,
Imeik Technology Co. Ltd,
Evercore,
Tungsten Financial,
Cascadia,
Capel Thompson & Homer Llp,
Stifel Europe,
Piper Sandler,
Orrick, Herrington & Sutcliffe Llp.
Tungsten Advisors's categories are Investment Banking
Tungsten Advisors's founding year is 2019
